This announcement is a separate document:
海普瑞：深圳市海普瑞药业集团股份有限公司2022年面向专业投资者公开发行公司债券2023年度付息公告
Hypertherm: Announcement on the public issuance of corporate bonds to professional investors by Shenzhen Haipuri Pharmaceutical Group Co., Ltd. in 2022 for the 2023 annual interest payment announcement
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.